Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2011-04-18
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This investigation will focus on two areas: 1) early communication impairments as predictors of autism spectrum disorder (ASD) and later developmental delays, and 2) the relationship between communication and evidence of CNS function (sleep, EEG) and structure (MRI DTI and volumetrics) in young children at risk for ASD. The objective is to delineate early communicative impairments that predict ASD vs. other developmental delays and to examine how these impairments correlate with brain abnormalities in both structure and function.
Study Population
We will recruit 64 children \[n=32 at 12 months of age (plus or minus 2 months); n=32 at 18 months of age (plus or minus 2 months)\] who are at-risk for ASD due to communication/language delays (at-risk group). The at-risk children will be matched at initial on chronological age, SES, and sex, to typically developing children (n=75) with no history of developmental delays. These 139 participants will hereafter be referred to as the toddler sample. At the 36 month final visit, diagnostic status (e.g. ASD, non-ASD specific delays, catch up) will be determined for children in the at-risk group. In addition, 10 healthy adults, aged 18-40 will serve as control participants for the purpose of piloting the functional paradigms for the MRI portion of the protocol.
Design
We propose to conduct a prospective, longitudinal study of toddlers at-risk for ASD compared to typically developing toddlers. Children will complete behavioral testing and an overnight Sleep/EEG as well as MRI at either a 12 or 18 month initial. Follow-up visits that include behavioral assessment will occur at 24 and 36 months for all children (and at 18 months of age for the 12-month cohort). The Sleep/EEG and MRI will be repeated at the 36 month final follow-up.
Outcome Measures
Autism symptoms, language status, and cognitive development at 36 months will serve as the primary outcome measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. 12 or 18 months of age (plus or minus 3 months)
2. Limited spoken words (for both the 12 and 18 month groups)
3. Expressive and Receptive scores in the Very Low range on the Mullen Scales of Early Learning (a standardized observational measure),
Typically Developing Group:
1. 12 or 18 months of age (plus or minor 3 months)
2. Development in nonverbal and verbal areas within age expectations (per scores on all 4 domains of the Mullen Scales of Early learning no more than 1.5 standard deviation below the mean).
Healthy Adult Group:
1\. 18-40 years old
Exclusion Criteria
1. Primary language spoken in the home is other than English
2. Prematurity at birth (defined as less than 36 weeks gestation), or birth weight significantly below normal for gestational age (SGA- small for gestational age) or other significant birth trauma.
3. Motor or other medical impairment deemed responsible for delays (e.g. cerebral palsy; known genetic disorder)
Typically Developing Group:
1. Primary language spoken in the home is other than English
2. Prematurity at birth (defined as less than 36 weeks gestation); or birth weight significantly below normal for gestational age (SGA- small for gestational age).
3. Motor or other medical impairment that would interfere with study participation
4. Known genetic disorder
5. Status as a younger sibling of a child diagnosed with autism
Healthy Adult Group:
1. Historical or current psychiatric, neurological, or serious medical illness
2. Primary language is other than English
3. Difficulty hearing (as some sounds and words will be presented during the MRI scan)
4. Head injury with loss of consciousness in the last year
5. Metal in the body which would make having an MRI scan unsafe, such as pacemakers, medication pumps, aneurysm clips, metallic prostheses (including metal pins and rods, heart valves or cochlear implants), shrapnel fragments, permanent eye liner or small metal fragments in the eye that welders and other metal workers may have.
6. Discomfort in small closed spaces (have claustrophobia) so that there would be discomfort in the MRI machine.
7. Inability to lie comfortably flat on the back for up to 60 minutes in the MRI scanner
8. If female, and pregnant
9. Inability to provide own consent
9 Months
21 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Audrey E Thurm, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Mental Health (NIMH)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Buschmann A, Jooss B, Rupp A, Dockter S, Blaschtikowitz H, Heggen I, Pietz J. Children with developmental language delay at 24 months of age: results of a diagnostic work-up. Dev Med Child Neurol. 2008 Mar;50(3):223-9. doi: 10.1111/j.1469-8749.2008.02034.x. Epub 2008 Feb 11.
Chawarska K, Klin A, Paul R, Volkmar F. Autism spectrum disorder in the second year: stability and change in syndrome expression. J Child Psychol Psychiatry. 2007 Feb;48(2):128-38. doi: 10.1111/j.1469-7610.2006.01685.x.
Dager SR, Wang L, Friedman SD, Shaw DW, Constantino JN, Artru AA, Dawson G, Csernansky JG. Shape mapping of the hippocampus in young children with autism spectrum disorder. AJNR Am J Neuroradiol. 2007 Apr;28(4):672-7.
Hong X, Farmer C, Kozhemiako N, Holmes GL, Thompson L, Manwaring S, Thurm A, Buckley A. Differences in sleep EEG coherence and spindle metrics in toddlers with and without receptive/expressive language delay: a prospective observational study. J Neurodev Disord. 2025 Feb 22;17(1):11. doi: 10.1186/s11689-024-09586-1.
Hong X, Farmer C, Kozhemiako N, Holmes GL, Thompson L, Manwaring S, Thurm A, Buckley A. Differences in Sleep EEG Coherence and Spindle Metrics in Toddlers With and Without Language Delay: A Prospective Observational Study. Res Sq [Preprint]. 2024 Feb 14:rs.3.rs-3904113. doi: 10.21203/rs.3.rs-3904113/v1.
Smith EG, Condy E, Anderson A, Thurm A, Manwaring SS, Swineford L, Gandjbakhche A, Redcay E. Functional near-infrared spectroscopy in toddlers: Neural differentiation of communicative cues and relation to future language abilities. Dev Sci. 2020 Nov;23(6):e12948. doi: 10.1111/desc.12948. Epub 2020 Mar 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-M-0144
Identifier Type: -
Identifier Source: secondary_id
110144
Identifier Type: -
Identifier Source: org_study_id